The Rett Syndrome Research Trust Strengthens Research Team with Addition of Robert Deans as Chief Technology Officer

The Rett Syndrome Research Trust (RSRT) is excited to announce the addition of Robert Deans, PhD, as Chief Technology Officer, Head of Research. Deans brings a wealth of genetic medicine knowledge and hands-on industry experience to RSRT. Most recently, he served as Chief Technology...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: PER Source Type: news